-
Signature
-
/s/ Richard Eskew, Attorney-in-Fact
-
Stock symbol
-
ACCD
-
Transactions as of
-
Jan 9, 2024
-
Transactions value $
-
-$1,119,930
-
Form type
-
4
-
Date filed
-
1/11/2024, 06:14 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ACCD |
Common Stock |
Sale |
-$543K |
-36.2K |
-4.88% |
$15.00 |
705K |
Jan 9, 2024 |
Direct |
F2, F3 |
transaction |
ACCD |
Common Stock |
Options Exercise |
$152K |
+36.2K |
+5.13% |
$4.20 |
741K |
Jan 9, 2024 |
Direct |
F2 |
transaction |
ACCD |
Common Stock |
Options Exercise |
$283K |
+67.3K |
+9.07% |
$4.20 |
809K |
Jan 10, 2024 |
Direct |
F2 |
transaction |
ACCD |
Common Stock |
Sale |
-$1.01M |
-67.3K |
-8.32% |
$15.03 |
741K |
Jan 10, 2024 |
Direct |
F2, F4 |
holding |
ACCD |
Common Stock |
|
|
|
|
|
652K |
Jan 9, 2024 |
By Avanti Holdings, LLC |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ACCD |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-36.2K |
-3.52% |
$0.00 |
994K |
Jan 9, 2024 |
Common Stock |
36.2K |
$4.20 |
Direct |
F5 |
transaction |
ACCD |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-67.3K |
-6.77% |
$0.00 |
926K |
Jan 10, 2024 |
Common Stock |
67.3K |
$4.20 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: